img Leseprobe Leseprobe

Cardio-Oncology

Management of Toxicities in the Era of Immunotherapy

Antonio Giordano (Hrsg.), Dimitrios Farmakis (Hrsg.), Antonio Russo (Hrsg.), Nicola Maurea (Hrsg.)

PDF
ca. 96,29
Amazon iTunes Thalia.de Weltbild.de Hugendubel Bücher.de ebook.de kobo Osiander Google Books Barnes&Noble bol.com Legimi yourbook.shop Kulturkaufhaus ebooks-center.de
* Affiliatelinks/Werbelinks
Hinweis: Affiliatelinks/Werbelinks
Links auf reinlesen.de sind sogenannte Affiliate-Links. Wenn du auf so einen Affiliate-Link klickst und über diesen Link einkaufst, bekommt reinlesen.de von dem betreffenden Online-Shop oder Anbieter eine Provision. Für dich verändert sich der Preis nicht.

Springer International Publishing img Link Publisher

Naturwissenschaften, Medizin, Informatik, Technik / Klinische Fächer

Beschreibung

The development of immunotherapy in oncology field has revolutionized the prognosis of many types of cancer. The immune checkpoint inhibitors target receptors whose inhibition increases the activity of immune system cells against tumor cells. In recent years, new immunotherapies have been studied and approved in a growing number of tumors including melanoma, non-small cell lung cancer (NSCLC), and renal cell cancer (RCC).

 
This volume provides a complete and updated state-of-art review regarding the management of cardiovascular toxicities from new immunotherapies. The manuscript is divided into different sections starting from the relationship between cancer and immune system to let the reader understand the new molecular concepts under immunotherapy development. Subsequent chapters describe specifically the immunotherapy options in solid tumor treatment and the main features of the immuno-related cardiovascular complications. This volume is written by experts in the oncological and cardiovascular fields and aims to provide to clinicians who approach current cancer patients a useful tool to move through the paths of modern cardio-oncology. An important section would afford the most relevant interventions needed to manage the cardiac events, suggesting how to reduce their impact and effects on oncological outcomes. The text concludes by addressing future perspectives in the cardio-immunology field, discussing many aspects such as the early detection of cardiovascular damage and the potential role of liquid biopsy in new damage-related biomarkers discovery.

Weitere Titel von diesem Autor
Weitere Titel in dieser Kategorie
Cover Dallas Rhinoplasty
William P. Adams Jr.
Cover Dallas Rhinoplasty
William P. Adams Jr.
Cover Heart
Paddy Barrett
Cover Asphyxia in Neonates
Miljana Z. Jovandaric
Cover Asphyxia in Neonates
Miljana Z. Jovandaric
Cover Scars
Lars-Peter Kamolz
Cover Magnificent Minds
Dr Suzanne Goh

Kundenbewertungen

Schlagwörter

cardiac toxicity, Immunology and cancer, Immunotherapy, Physiopathology, Biomarkers